People who are rapid cytochrome P-450 2D6 metabolizers practical experience a more robust tramadol opioid reaction and therefore are at an elevated possibility for abusing or overdosing with tramadol. Consequently, clinicians are inspired to consider using pharmacogenetic tests to forecast an individual’s reaction, possibility of dependancy, and